What are the specific symptoms associated with Giardia infection? Why does the organism cause these specific symptoms? What antibiotic can be used for both anaerobic bacterial infections and also the treatment of this protozoal infection?
Describe the process of embryonic patterning by morphogen gradients and explain the “French flag” model.
Explain what epigenetics is and describe the two key molecular mechanisms of epigenetic gene regulation. Give an example of an epigenetic disease and briefly describe a molecular method used to diagnose that disease
Describe the process of DNA sequencing using the Sanger (Dideoxy) method. Include as part of your answer an explanation of how the nucleotides involved are modified and how the base identity at each position is deduced.
Sequencing the human genome provided much information on elements that scientists knew existed but had little information on the structure of, such as (select all that apply): a) Protein binding sites b) Origins of replication c) Promoter d) Enhancers
Imagine an autosomal co-dominant trait with three different alleles: A, B, and C. For each of the following families, identify the possible nondisjunction events (rare mistakes during meiosis) that could explain the genotype of the offspring. Assume no recombination occurs.
Archaeological evidence documents thousands of years of domestication and cultivation of plants by artificial selection of genetic variants from wild populations
What are the advantages of using the correlational research method? Mark all that apply. O Correlational research is a simpler design than the experimental method. O This method shows the strength and direction of the relationship between two variables. O No answer text provided.
Explain why it is important that meiosis is a reductional division. Name two events that occur during meiosis that promote genetic variation. Compare and contrast the outcomes of autosomal, sex-linked, dominant, and recessive modes of inheritance.
You are reading a research paper that concludes that a new oral hypoglycemic agent can reduce fasting blood glucose by 3mmol/L (p<0.05). Interpret the result and comment on the clinical use, and statistical and clinical significance of this piece of information.
